Evidence map›Paper›PMID 32107486›Full record

ArticlePloS one2020

Assessment of the nail penetration of antifungal agents, with different physico-chemical properties.

H Davies-Strickleton, Julie Cook, Sally Hannam, Rhys Bennett, Alan Gibbs, David Edwards, Christine Ridden, John Ridden, David Cook

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Fractional COLasers in surgery and medicine · 2022
    Article
  9. Updated Perspectives on the Diagnosis and Management of Onychomycosis.Clinical, cosmetic and investigational dermatology · 2022
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

H Davies-StrickletonBlueberry Therapeutics Limited, Alderley Park, Alderley Edge, Cheshire, United Kingdom.ORCID 0000-0003-4715-3111
Julie CookBlueberry Therapeutics Limited, Alderley Park, Alderley Edge, Cheshire, United Kingdom.
Sally HannamAlderley Analytical Limited, Alderley Park, Alderley Edge, Cheshire, United Kingdom.
Rhys BennettAlderley Analytical Limited, Alderley Park, Alderley Edge, Cheshire, United Kingdom.
Alan GibbsAlderley Analytical Limited, Alderley Park, Alderley Edge, Cheshire, United Kingdom.
David EdwardsBlueberry Therapeutics Limited, Alderley Park, Alderley Edge, Cheshire, United Kingdom.
Christine RiddenBlueberry Therapeutics Limited, Alderley Park, Alderley Edge, Cheshire, United Kingdom.
John RiddenBlueberry Therapeutics Limited, Alderley Park, Alderley Edge, Cheshire, United Kingdom.
David CookBlueberry Therapeutics Limited, Alderley Park, Alderley Edge, Cheshire, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Onychomycosis, or fungal nail infection, is a common fungal infection largely caused by dermatophyte fungi, such as Trichophyton rubrum or Trichophyton mentagrophytes, which affects a significant number of people. Treatment is either through oral antifungal medicines, which are efficacious but have significant safety concerns, or with topical antifungal treatments that require long treatment regimens and have only limited efficacy. Thus, an efficacious topical therapy remains an unmet medical need. Among the barriers to topical delivery through the nail are the physico-chemical properties of the antifungal drugs. Here, we explore the ability of a range of antifungal compounds with different hydrophilicities to penetrate the nail. Human nail discs were clamped within static diffusion (Franz) cells and dosed with equimolar concentrations of antifungal drugs. Using LC-MS/MS we quantified the amount of drug that passed through the nail disc and that which remained associated with the nail. Our data identified increased drug flux through the nail for the more hydrophilic compounds (caffeine as a hydrophilic control and fluconazole, with LogP -0.07 and 0.5, respectively), while less hydrophilic efinaconazole, amorolfine and terbinafine (LogP 2.7, 5.6 and 5.9 respectively) had much lower flux through the nail. On the other hand, hydrophilicity alone did not account for the amount of drug associated with/bound to the nail itself. While there are other factors that are likely to combine to dictate nail penetration, this work supports earlier studies that implicate compound hydrophilicity as a critical factor for nail penetration.

Indexed as

Administration, TopicalAntifungal AgentsHumansHydrophobic and Hydrophilic InteractionsMycosesNail DiseasesNailsPermeabilityTissue DistributionAntifungal Agents

Identifiers

PMID32107486
PMCPMC7046211
OpenAlexW3008883498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.